1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA FAM222B CTRPv2 pan-cancer AAC 0.093 0.01
mRNA BUD13 CTRPv2 pan-cancer AAC -0.096 0.01
mRNA SEC22B CTRPv2 pan-cancer AAC -0.1 0.01
mRNA DEPDC4 CTRPv2 pan-cancer AAC -0.092 0.01
mRNA CYFIP2 CTRPv2 pan-cancer AAC -0.11 0.01
mRNA TCHHL1 CTRPv2 pan-cancer AAC 0.089 0.01
mRNA ART1 CTRPv2 pan-cancer AAC 0.09 0.01
mRNA CYP2S1 CTRPv2 pan-cancer AAC 0.1 0.01
mRNA SENP2 CTRPv2 pan-cancer AAC -0.091 0.01
mRNA MESDC1 CTRPv2 pan-cancer AAC 0.095 0.01
Download CSV